<p>Alignment Healthcare（納斯達克：ALHC - 獲取免費報告）在週三發佈的研究報告中，摩根大通的股票研究人員將其目標價從 20.00 美元上調至 23.00 美元。該公司目前對該股票的評級為 “超配”。摩根大通的目標價表明，相較於公司當前價格，存在 12.03% 的潛在上漲空間。</p>
<p>ALHC 已經成為其他幾份研究報告的主題。高盛集團在 11 月 3 日的研究報告中重申了對 Alignment Healthcare 的 “買入” 評級，並給出了 22.00 美元的目標價。Weiss Ratings 在 10 月 8 日的報告中重申了對 Alignment Healthcare 的 “賣出（d-）” 評級。KeyCorp 在 11 月 24 日的研究報告中重申了對 Alignment Healthcare 的 “超配” 評級。巴克萊在 10 月 31 日的研究報告中將 Alignment Healthcare 的目標價從 13.00 美元上調至 18.00 美元，並給予該公司 “等權重” 評級。最後，華爾街 Zen 在 11 月 8 日的報告中將 Alignment Healthcare 的評級從 “持有” 上調至 “買入”。一位股票研究分析師給予該股票 “強烈買入” 評級，八位分析師給予 “買入” 評級，三位分析師給予 “持有” 評級，一位分析師給予 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，共識目標價為 20.35 美元。</p>
<p>獲取 <strong>Alignment Healthcare</strong> 警報：</p>
<p><strong>閲讀我們對 ALHC 的最新分析</strong></p>
<h2>Alignment Healthcare 股票上漲 2.5%</h2>
<p>在週三的交易中，ALHC 股票上漲 0.50 美元，達到 20.53 美元。該公司股票的交易量為 1,002,049 股，而其平均交易量為 3,029,211 股。該公司的市值為 41.1 億美元，市盈率為-171.06，貝塔值為 1.16。Alignment Healthcare 的 1 年最低價為 10.18 美元，1 年最高價為 21.06 美元。該公司的速動比率為 1.61，流動比率為 1.61，債務與股本比率為 1.99。該公司的 50 日簡單移動平均線為 17.77 美元，200 日簡單移動平均線為 15.91 美元。</p>
<p>Alignment Healthcare（納斯達克：ALHC - 獲取免費報告）最後一次發佈財報是在 10 月 30 日，報告顯示該公司季度每股收益為 0.02 美元，超出分析師共識預期的-0.01 美元，超出幅度為 0.03 美元。Alignment Healthcare 的股本回報率為-16.23%，淨利潤率為-0.57%。該公司在本季度的收入為 9.937 億美元，而分析師預期為 9.809 億美元。在去年同期，該公司的每股收益為-0.14 美元。Alignment Healthcare 的收入同比增長 43.5%。賣方分析師預計 Alignment Healthcare 在本年度的每股收益為-0.69 美元。</p>
<h2>Alignment Healthcare 的內部活動</h2>
<p>在相關消息中，首席執行官 John E. Kao 在 12 月 10 日的交易中出售了 180,000 股公司的股票，交易價格為 19.02 美元，總價值為 3,423,600.00 美元。交易完成後，首席執行官直接持有公司 2,346,726 股，價值 44,634,728.52 美元。此次交易使其持股減少了 7.12%。該交易已在向 SEC 提交的文件中披露，相關文件可在 SEC 網站上查閲。此外，首席運營官 Sebastian Burzacchi 在 12 月 10 日的交易中出售了 12,585 股公司的股票，交易價格為 19.26 美元，總交易額為 242,387.10 美元。交易完成後，首席運營官持有 237,793 股公司的股票，價值約為 4,579,893.18 美元。此次交易使其持股減少了 5.03%。該銷售的披露信息可在 SEC 文件中找到。內部人士在過去三個月內出售了 842,157 股公司股票，價值 15,187,475 美元。公司內部人士持有公司股票的 6.60%。</p>
<h2>Alignment Healthcare 的機構交易</h2>
<p>最近，一些機構投資者和對沖基金已修改其對 ALHC 的持股。Wellington Management Group LLP 在第三季度將其在 Alignment Healthcare 的持股增加了 167.3%。Wellington Management Group LLP 現在擁有 11,089,727 股公司股票，價值 193,516,000 美元，在上個季度又購買了 6,940,277 股。Invesco Ltd.在第二季度將其在 Alignment Healthcare 的持股增加了 122.3%。Invesco Ltd.現在擁有 4,170,529 股公司股票，價值 58,387,000 美元，在上個季度又收購了 2,294,739 股。Vanguard Group Inc.在第一季度將其在 Alignment Healthcare 的持股增加了 13.2%。Vanguard Group Inc.現在擁有 11,113,896 股公司股票，價值 206,941,000 美元，在上個季度又收購了 1,295,825 股。Marshall Wace LLP 在第二季度將其在 Alignment Healthcare 的持股增加了 173.3%。Marshall Wace LLP 現在擁有 2,039,714 股公司股票，價值 28,556,000 美元，在上個季度又購買了 1,293,416 股。最後，Voya Investment Management LLC 在第三季度將其在 Alignment Healthcare 的持股增加了 61.0%。Voya Investment Management LLC 現在擁有 3,196,297 股公司股票，價值 55,775,000 美元，在上個季度又購買了 1,210,930 股。對沖基金和其他機構投資者持有公司股票的 86.19%。</p>
<h2>Alignment Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國老年人提供以消費者為中心的醫療保健平台。它通過醫療保險優勢計劃提供定製的醫療保健，以滿足多樣化老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Alignment Healthcare</li>
<li>外匯是什麼，如何運作？</li>
<li>特斯拉被高估了嗎？可能是便宜貨的兩個理由</li>
<li>如何繪製斐波那契價格拐點水平</li>
<li>這兩隻股票如何贏得 2025 年的人工智能競賽——2026 年又將如何</li>
<li>百分比漲幅告訴投資者什麼，以及為什麼它們並不能講述全部故事</li>
<li>英特爾以低價收購人工智能技術</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Alignment Healthcare 嗎？</h2>
<p>在你考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Alignment Healthcare 並不在名單上。</p>
<p>雖然 Alignment Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ALHC

<p>摩根大通將 Alignment Healthcare（NASDAQ:ALHC）的目標股價從 20.00 美元上調至 23.00 美元，維持 “增持” 評級，暗示潛在上漲幅度為 12.03%。該股票的共識評級為 “適度買入”，目標價格為 20.35 美元。近期內部交易中，首席執行官 John E. Kao 和首席運營官 Sebastian Burzacchi 進行了大量股票出售。機構投資者如 Wellington Management 和 Invesco 已增加在該公司的持股</p>

<p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) had its price target upped by equities researchers at JPMorgan Chase &amp; Co. from $20.00 to $23.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an &#34;overweight&#34; rating on the stock. JPMorgan Chase &amp; Co.'s target price indicates a potential upside of 12.03% from the company's current price.</p>
<div class="lb-trans"><p>Alignment Healthcare（納斯達克：ALHC - 獲取免費報告）在週三發佈的研究報告中，摩根大通的股票研究人員將其目標價從 20.00 美元上調至 23.00 美元。該公司目前對該股票的評級為 “超配”。摩根大通的目標價表明，相較於公司當前價格，存在 12.03% 的潛在上漲空間。</p>
</div><p>ALHC has been the topic of several other research reports. The Goldman Sachs Group reiterated a &#34;buy&#34; rating and issued a $22.00 target price on shares of Alignment Healthcare in a research note on Monday, November 3rd. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. KeyCorp reiterated an &#34;overweight&#34; rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Barclays increased their target price on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an &#34;equal weight&#34; rating in a research report on Friday, October 31st. Finally, Wall Street Zen raised shares of Alignment Healthcare from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, November 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $20.35.</p>
<div class="lb-trans"><p>ALHC 已經成為其他幾份研究報告的主題。高盛集團在 11 月 3 日的研究報告中重申了對 Alignment Healthcare 的 “買入” 評級，並給出了 22.00 美元的目標價。Weiss Ratings 在 10 月 8 日的報告中重申了對 Alignment Healthcare 的 “賣出（d-）” 評級。KeyCorp 在 11 月 24 日的研究報告中重申了對 Alignment Healthcare 的 “超配” 評級。巴克萊在 10 月 31 日的研究報告中將 Alignment Healthcare 的目標價從 13.00 美元上調至 18.00 美元，並給予該公司 “等權重” 評級。最後，華爾街 Zen 在 11 月 8 日的報告中將 Alignment Healthcare 的評級從 “持有” 上調至 “買入”。一位股票研究分析師給予該股票 “強烈買入” 評級，八位分析師給予 “買入” 評級，三位分析師給予 “持有” 評級，一位分析師給予 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，共識目標價為 20.35 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Alignment Healthcare</strong> 警報：</p>
</div><p><strong>Read Our Latest Analysis on ALHC</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 ALHC 的最新分析</strong></p>
</div><h2>Alignment Healthcare Stock Up 2.5%</h2>
<div class="lb-trans"><h2>Alignment Healthcare 股票上漲 2.5%</h2>
</div><p>ALHC stock traded up $0.50 during trading on Wednesday, hitting $20.53. 1,002,049 shares of the company's stock traded hands, compared to its average volume of 3,029,211. The firm has a market capitalization of $4.11 billion, a P/E ratio of -171.06 and a beta of 1.16. Alignment Healthcare has a 1 year low of $10.18 and a 1 year high of $21.06. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The business has a fifty day simple moving average of $17.77 and a two-hundred day simple moving average of $15.91.</p>
<div class="lb-trans"><p>在週三的交易中，ALHC 股票上漲 0.50 美元，達到 20.53 美元。該公司股票的交易量為 1,002,049 股，而其平均交易量為 3,029,211 股。該公司的市值為 41.1 億美元，市盈率為-171.06，貝塔值為 1.16。Alignment Healthcare 的 1 年最低價為 10.18 美元，1 年最高價為 21.06 美元。該公司的速動比率為 1.61，流動比率為 1.61，債務與股本比率為 1.99。該公司的 50 日簡單移動平均線為 17.77 美元，200 日簡單移動平均線為 15.91 美元。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The company had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. During the same quarter in the prior year, the business earned ($0.14) earnings per share. Alignment Healthcare's revenue was up 43.5% on a year-over-year basis. Sell-side analysts anticipate that Alignment Healthcare will post -0.69 EPS for the current year.</p>
<div class="lb-trans"><p>Alignment Healthcare（納斯達克：ALHC - 獲取免費報告）最後一次發佈財報是在 10 月 30 日，報告顯示該公司季度每股收益為 0.02 美元，超出分析師共識預期的-0.01 美元，超出幅度為 0.03 美元。Alignment Healthcare 的股本回報率為-16.23%，淨利潤率為-0.57%。該公司在本季度的收入為 9.937 億美元，而分析師預期為 9.809 億美元。在去年同期，該公司的每股收益為-0.14 美元。Alignment Healthcare 的收入同比增長 43.5%。賣方分析師預計 Alignment Healthcare 在本年度的每股收益為-0.69 美元。</p>
</div><h2>Insider Activity at Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的內部活動</h2>
</div><p>In related news, CEO John E. Kao sold 180,000 shares of the business's stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $19.02, for a total value of $3,423,600.00. Following the completion of the transaction, the chief executive officer directly owned 2,346,726 shares in the company, valued at $44,634,728.52. The trade was a 7.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Sebastian Burzacchi sold 12,585 shares of the company's stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $19.26, for a total transaction of $242,387.10. Following the completion of the transaction, the chief operating officer owned 237,793 shares of the company's stock, valued at approximately $4,579,893.18. This trade represents a 5.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 842,157 shares of company stock worth $15,187,475 in the last three months. Company insiders own 6.60% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 John E. Kao 在 12 月 10 日的交易中出售了 180,000 股公司的股票，交易價格為 19.02 美元，總價值為 3,423,600.00 美元。交易完成後，首席執行官直接持有公司 2,346,726 股，價值 44,634,728.52 美元。此次交易使其持股減少了 7.12%。該交易已在向 SEC 提交的文件中披露，相關文件可在 SEC 網站上查閲。此外，首席運營官 Sebastian Burzacchi 在 12 月 10 日的交易中出售了 12,585 股公司的股票，交易價格為 19.26 美元，總交易額為 242,387.10 美元。交易完成後，首席運營官持有 237,793 股公司的股票，價值約為 4,579,893.18 美元。此次交易使其持股減少了 5.03%。該銷售的披露信息可在 SEC 文件中找到。內部人士在過去三個月內出售了 842,157 股公司股票，價值 15,187,475 美元。公司內部人士持有公司股票的 6.60%。</p>
</div><h2>Institutional Trading of Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的機構交易</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of ALHC. Wellington Management Group LLP increased its stake in Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company's stock worth $193,516,000 after buying an additional 6,940,277 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock worth $58,387,000 after acquiring an additional 2,294,739 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 13.2% in the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after acquiring an additional 1,295,825 shares during the last quarter. Marshall Wace LLP increased its position in shares of Alignment Healthcare by 173.3% during the second quarter. Marshall Wace LLP now owns 2,039,714 shares of the company's stock worth $28,556,000 after purchasing an additional 1,293,416 shares in the last quarter. Finally, Voya Investment Management LLC raised its stake in Alignment Healthcare by 61.0% in the 3rd quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company's stock valued at $55,775,000 after purchasing an additional 1,210,930 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.</p>
<div class="lb-trans"><p>最近，一些機構投資者和對沖基金已修改其對 ALHC 的持股。Wellington Management Group LLP 在第三季度將其在 Alignment Healthcare 的持股增加了 167.3%。Wellington Management Group LLP 現在擁有 11,089,727 股公司股票，價值 193,516,000 美元，在上個季度又購買了 6,940,277 股。Invesco Ltd.在第二季度將其在 Alignment Healthcare 的持股增加了 122.3%。Invesco Ltd.現在擁有 4,170,529 股公司股票，價值 58,387,000 美元，在上個季度又收購了 2,294,739 股。Vanguard Group Inc.在第一季度將其在 Alignment Healthcare 的持股增加了 13.2%。Vanguard Group Inc.現在擁有 11,113,896 股公司股票，價值 206,941,000 美元，在上個季度又收購了 1,295,825 股。Marshall Wace LLP 在第二季度將其在 Alignment Healthcare 的持股增加了 173.3%。Marshall Wace LLP 現在擁有 2,039,714 股公司股票，價值 28,556,000 美元，在上個季度又購買了 1,293,416 股。最後，Voya Investment Management LLC 在第三季度將其在 Alignment Healthcare 的持股增加了 61.0%。Voya Investment Management LLC 現在擁有 3,196,297 股公司股票，價值 55,775,000 美元，在上個季度又購買了 1,210,930 股。對沖基金和其他機構投資者持有公司股票的 86.19%。</p>
</div><h2>Alignment Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Alignment Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國老年人提供以消費者為中心的醫療保健平台。它通過醫療保險優勢計劃提供定製的醫療保健，以滿足多樣化老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>What is Forex and How Does it Work?</li>
<li>Is Tesla Overvalued? 2 Reasons It Might Be a Bargain</li>
<li>How to Plot Fibonacci Price Inflection Levels</li>
<li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li>
<li>What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story</li>
<li>Intel Snaps Up AI Tech for Pennies on the Dollar</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Alignment Healthcare</li>
<li>外匯是什麼，如何運作？</li>
<li>特斯拉被高估了嗎？可能是便宜貨的兩個理由</li>
<li>如何繪製斐波那契價格拐點水平</li>
<li>這兩隻股票如何贏得 2025 年的人工智能競賽——2026 年又將如何</li>
<li>百分比漲幅告訴投資者什麼，以及為什麼它們並不能講述全部故事</li>
<li>英特爾以低價收購人工智能技術</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ALHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Alignment Healthcare 嗎？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Alignment Healthcare 並不在名單上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Alignment Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

摩根大通公司將 Alignment Healthcare（納斯達克代碼：ALHC）的目標股價上調至 23.00 美元